Abstract:Significance: Reactive oxygen species (ROS) are generated during mitochondrial oxidative metabolism, and are tightly controlled through homeostatic mechanisms to maintain intracellular redox, regulating growth and proliferation in healthy cells. However, ROS production is perturbed in cancers where abnormal accumulation of ROS leads to oxidative stress and genomic instability, triggering oncogenic signaling pathways on one hand, while increasing oxidative damage and triggering ROS-dependent death signaling on the other. Recent Advances: Our review illuminates how critical interactions between ROS and oncogenic signaling, the tumor microenvironment, and DNA damage response (DDR) pathways have led to interest in ROS modulation as a means of enhancing existing anticancer strategies and developing new therapeutic opportunities. Critical Issues: ROS equilibrium exists via a delicate balance of pro-oxidant and antioxidant species within cells. "Antioxidant" approaches have been explored mainly in the form of chemoprevention, but there is insufficient evidence to advocate its routine application. More progress has been made via the "pro-oxidant" approach of targeting cancer vulnerabilities and inducing oxidative stress. Various therapeutic modalities have employed this approach, including direct ROS-inducing agents, chemotherapy, targeted therapies, DDR therapies, radiotherapy, and immunotherapy. Finally, emerging delivery systems such as "nanosensitizers" as radiotherapy enhancers are currently in development. Future Directions: While approaches designed to induce ROS have shown considerable promise in selectively targeting cancer cells and dealing with resistance to conventional therapies, most are still in early phases of development and challenges remain. Further research should endeavor to refine treatment strategies, optimize drug combinations, and identify predictive biomarkers of ROS-based cancer therapies.

Mitochondrial Dynamics, ROS, and Cell Signaling: A Blended Overview

Mitochondrial Fragmentation and ROS Signaling in Wound Response and Repair

Reactive Oxygen Species and Mitochondrial Dynamics: The Yin and Yang of Mitochondrial Dysfunction and Cancer Progression

The Complex Interplay between Mitochondria, ROS and Entire Cellular Metabolism

Post-translational modifications in mitochondria: protein signaling in the powerhouse

Mitochondria and Mitochondrial ROS in Cancer: Novel Targets for Anticancer Therapy

Unraveling mitochondria‐targeting reactive oxygen species modulation and their implementations in cancer therapy by nanomaterials

Mitochondria as intracellular signalling organelles. An update

The Role of Mitochondrial Dynamics and Mitophagy in Carcinogenesis, Metastasis and Therapy.

The mitochondrial stress signaling tunes immunity from a view of systemic tumor microenvironment and ecosystem

Targeting mitochondrial reactive oxygen species as novel therapy for inflammatory diseases and cancers

Mitochondrial Redox Signaling And Tumor Progression

Mitochondria-Ros Crosstalk in the Control of Cell Death and Aging

ROS and ROS-Mediated Cellular Signaling

Microtubule-Based Mitochondrial Dynamics as a Valuable Therapeutic Target in Cancer

Mitochondrial trafficking and redox/phosphorylation signaling supporting cell migration phenotypes

Mitochondria in health, disease, and aging

Mitochondrial Reactive Oxygen Species and Mitophagy: A Complex and Nuanced Relationship

Role of mitochondrial reactive oxygen species in homeostasis regulation

Navigating the landscape of mitochondrial-ER communication in health and disease

Reactive Oxygen Species Modulation in the Current Landscape of Anticancer Therapies